Wendell David Associates Inc Novo Nordisk A S Transaction History

Wendell David Associates Inc

$994 Million
Q2 2025

A detailed history of Wendell David Associates Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Wendell David Associates Inc holds 72,802 shares of NVO stock, worth $3.85 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares

72,802

Previous 76,777 5.18%

Holding current value

$3.85 Million

Previous $5.33 Million 5.74%

% of portfolio

0.51%

Previous 0.53%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 29, 2025	SELL	$58.08 - $81.05 $230,868 - $322,173	-3,975 Reduced 5.18%	72,802 $5.03 Million
Q1 2025 Apr 18, 2025	SELL	$69.3 - $90.95 $4,851 - $6,366	-70 Reduced 0.09%	76,777 $5.33 Million
Q4 2024 Jan 17, 2025	BUY	$85.0 - $120.04 $19,125 - $27,009	225 Added 0.29%	76,847 $6.61 Million
Q3 2024 Oct 21, 2024	SELL	$119.07 - $145.42 $59,535 - $72,710	-500 Reduced 0.65%	76,622 $9.12 Million
Q2 2024 Jul 22, 2024	SELL	$122.71 - $146.91 $12,271 - $14,691	-100 Reduced 0.13%	77,122 $11 Million
Q1 2024 Apr 22, 2024	SELL	$102.11 - $135.92 $25,323 - $33,708	-248 Reduced 0.32%	77,222 $9.92 Million
Q4 2023 Jan 22, 2024	BUY	$87.78 - $105.45 $614,460 - $738,150	7,000 Added 9.93%	77,470 $8.01 Million
Q3 2023 Oct 20, 2023	BUY	$90.94 - $199.54 $3.21 Million - $7.05 Million	35,335 Added 100.57%	70,470 $6.41 Million
Q2 2023 Jul 20, 2023	SELL	$155.98 - $172.65 $88,752 - $98,237	-569 Reduced 1.59%	35,135 $5.69 Million
Q1 2023 Apr 19, 2023	SELL	$132.34 - $159.14 $266,665 - $320,667	-2,015 Reduced 5.34%	35,704 $5.68 Million
Q2 2022 Jul 14, 2022	SELL	$103.24 - $121.81 $36,030 - $42,511	-349 Reduced 0.92%	37,719 $4.2 Million
Q1 2022 Apr 22, 2022	SELL	$93.1 - $112.54 $353,780 - $427,652	-3,800 Reduced 9.08%	38,068 $4.23 Million
Q4 2021 Jan 24, 2022	BUY	$95.88 - $117.08 $4,698 - $5,736	49 Added 0.12%	41,868 $4.69 Million
Q3 2021 Oct 19, 2021	BUY	$84.42 - $106.62 $39,592 - $50,004	469 Added 1.13%	41,819 $4.02 Million
Q2 2021 Jul 19, 2021	SELL	$67.66 - $84.76 $71,043 - $88,998	-1,050 Reduced 2.48%	41,350 $3.46 Million
Q3 2020 Oct 20, 2020	SELL	$63.69 - $70.22 $55,728 - $61,442	-875 Reduced 2.02%	42,400 $2.94 Million
Q2 2020 Jul 17, 2020	SELL	$58.54 - $67.94 $23,416 - $27,176	-400 Reduced 0.92%	43,275 $2.83 Million
Q3 2019 Oct 22, 2019	SELL	$47.54 - $53.43 $172,332 - $193,683	-3,625 Reduced 7.66%	43,675 $2.26 Million
Q2 2019 Jul 16, 2019	SELL	$46.79 - $52.47 $10,527 - $11,805	-225 Reduced 0.47%	47,300 $2.41 Million
Q4 2018 Jan 17, 2019	SELL	$41.54 - $47.25 $44,364 - $50,463	-1,068 Reduced 2.2%	47,525 $2.19 Million
Q3 2018 Oct 12, 2018	SELL	$46.76 - $51.24 $51,436 - $56,364	-1,100 Reduced 2.21%	48,593 $2.29 Million
Q1 2018 Apr 11, 2018	SELL	$48.49 - $58.14 $67,886 - $81,396	-1,400 Reduced 2.74%	49,693 $2.45 Million
Q4 2017 Jan 16, 2018	SELL	$47.53 - $53.73 $65,021 - $73,502	-1,368 Reduced 2.61%	51,093 $2.74 Million
Q3 2017 Oct 17, 2017	BUY	$41.15 - $49.22 $2.16 Million - $2.58 Million	52,461	52,461 $2.53 Million

Others Institutions Holding NVO

# of Institutions

1,705

Shares Held

311M

Call Options Held

13.7M

Put Options Held

19.7M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $119B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wendell David Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wendell David Associates Inc with notifications on news.

Account

Wendell David Associates Inc Novo Nordisk A S Transaction History